title: Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes.
authors.affiliation: Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio 44195, USA. sekerem@ccf.org
authors.forename: Mikkael A
authors.initials: MA
authors.lastname: Sekeres
authors.forename: Hagop
authors.initials: H
authors.lastname: Kantarjian
authors.forename: Pierre
authors.initials: P
authors.lastname: Fenaux
authors.forename: Pamela
authors.initials: P
authors.lastname: Becker
authors.forename: Adam
authors.initials: A
authors.lastname: Boruchov
authors.forename: Agnes
authors.initials: A
authors.lastname: Guerci-Bresler
authors.forename: Kuolung
authors.initials: K
authors.lastname: Hu
authors.forename: Janet
authors.initials: J
authors.lastname: Franklin
authors.forename: Yow-Ming C
authors.initials: YM
authors.lastname: Wang
authors.forename: Dietmar
authors.initials: D
authors.lastname: Berger